Milestone successfully delivered: 3rd Street Diagnostics and QMUL Licence agreement – Development of a diagnostic test for the early detection of pancreatic cancer
The second instalment of a licence payment was received by QMUL from 3rd Street Diagnostics in October under the terms of a Licence Agreement signed last year. This followed the successful evaluation of patient samples in a diagnostic test by 3rd Street Diagnostics for the early detection of Pancreatic Ductal Adenocarcinoma (PDAC), devised and developed at QMUL by Principal Investigator Dr Tatjana Crnogorac- Jurcevic.
Chromosol, a Queen Mary University of London (QMUL) spin-out, has received investment to commercialise a new material technology which could drastically cut energy use and increase the speed of optical communications.
QMUL spin out receives investment to develop energy-saving optical communications technology A Queen Mary University of London (QMUL)...
BioMoti, Pharmidex and Queen Mary University of London secure £662,222 Biomedical Catalyst award BioMoti, Pharmidex and Queen Mary...
If you would like to find out more information about our technologies or have any queries, please contact the relevant team member using our contact information found on our team profiles.